KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
19.24
+0.08 (0.42%)
At close: Apr 28, 2026, 4:00 PM EDT
26.66
+7.42 (38.57%)
Pre-market: Apr 29, 2026, 8:02 AM EDT
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $985.52 million as of April 29, 2026. Its market cap has increased by 88.08% in one year.
Market Cap
985.52M
Enterprise Value
969.51M
1-Year Change
88.08%
Ranking
Category
Stock Price
$19.24
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $985.52M, an increase of 662.20%. That is a compound annual growth rate of 20.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 981.40M | 20.23% |
| Dec 31, 2025 | 816.30M | 95.01% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 1.06B |
| Xeris Biopharma Holdings | 1.05B |
| Inventiva | 1.05B |
| Aktis Oncology | 1.03B |
| Fortrea Holdings | 1.01B |
| Annexon | 975.04M |
| ORIC Pharmaceuticals | 968.46M |
| Geron | 967.76M |